Strategic Partners A/S (CPH:STRAP)
Denmark · Delayed Price · Currency is DKK 695.00
0.00 (0.00%)
Aug 27, 2026, 12:36 PM CET
Strategic Partners Market Cap
Strategic Partners has a market cap or net worth of 28.99 million as of August 28, 2026. Its market cap has decreased by -33.17% in one year.
Market Cap
28.99M
Enterprise Value
12.46M
Revenue
304.00K
Ranking
n/a
PE Ratio
21.81
Stock Price
695.00
ChartMarket Cap Chart
Since November 21, 2017, Strategic Partners's market cap has decreased from 1.59B to 28.99M, a decrease of -98.18%. That is a compound annual growth rate of -36.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 28.99M | -0.43% |
| Dec 30, 2025 | 29.11M | -15.40% |
| Dec 30, 2024 | 34.42M | -26.72% |
| Dec 29, 2023 | 46.96M | 51.14% |
| Dec 30, 2022 | 31.07M | -94.82% |
| Dec 30, 2021 | 599.78M | -74.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.36T |
| Genmab | 131.10B |
| Coloplast | 104.37B |
| Demant | 60.02B |
| Gubra | 6.61B |
| BioPorto | 613.94M |
| Pharma Equity Group | 104.34M |
| ViroGates | 91.89M |